CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $863,000 | -20.8% | 32,000 | 0.0% | 0.01% | +44.4% |
| Q1 2022 | $1,090,000 | -39.3% | 32,000 | -31.2% | 0.01% | -40.0% |
| Q4 2021 | $1,797,000 | -28.8% | 46,500 | 0.0% | 0.02% | -16.7% |
| Q3 2021 | $2,524,000 | +62.3% | 46,500 | 0.0% | 0.02% | +50.0% |
| Q2 2021 | $1,555,000 | +62.3% | 46,500 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $958,000 | +17.5% | 46,500 | 0.0% | 0.01% | -37.5% |
| Q4 2020 | $815,000 | +18.1% | 46,500 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $690,000 | – | 46,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |